Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 516-524
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.516
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.516
Figure 2 Survival curves of the 40 cases of gastric neuroendocrine carcinomas according to (A) tumor location, (B) lymph node metastasis number, (C) liver metastasis, (D) postoperative chemotherapy.
EP: Etoposide plus cisplatin; EP + PTX: EP plus Paclitaxel.
- Citation: Liu DJ, Fu XL, Liu W, Zheng LY, Zhang JF, Huo YM, Li J, Hua R, Liu Q, Sun YW. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas. World J Gastroenterol 2017; 23(3): 516-524
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/516.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.516